In vivo assessment of toxicity and pharmacokinetics of methylglyoxal
US9198896B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 18, 2010 |
| Grant date | Dec 1, 2015 |
| Priority date | — |
| Expiry date | Aug 26, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition and treatment method to reduce the proliferation of cancerous or tumor cells, in which the combined active agents are methylglyoxal, ascorbic acid, creatine and melatonin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.